6.5 C
New York
Sunday, February 28, 2021

Precision BioSciences

- Advertisement -

FDA Accepts Precision BioSciences Inc (DTIL) PBCAR19B for treatment of NHL Disease

Precision BioSciences Inc (DTIL), a clinical biotech firm, recently announced that FDA has accepted its application for PBCAR19B as an Investigation New Drug (IND)....
- Advertisement -

Must Read

- Advertisement -